Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Preferred Stock Liabilities (2022)

Historic Preferred Stock Liabilities for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Q4 2022 value amounting to $67.7 million.

  • Orchestra BioMed Holdings' Preferred Stock Liabilities changed N/A to $67.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $67.7 million, marking a year-over-year change of. This contributed to the annual value of $67.7 million for FY2022, which is N/A changed from last year.
  • As of Q4 2022, Orchestra BioMed Holdings' Preferred Stock Liabilities stood at $67.7 million.
  • Orchestra BioMed Holdings' Preferred Stock Liabilities' 5-year high stood at $160.1 million during Q2 2022, with a 5-year trough of $67.7 million in Q3 2022.